The invention relates to the use of compounds of formula (I) and the pharmaceutically acceptable salts thereof for the treatment or the prevention of ocular inflammatory diseases, especially for the treatment and/or prevention of uveitis, severe conjunctivitis, dry eye syndrome or diabetic retinopathy.